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Acute lymphoblastic leukaemia (ALL), the most common child-
hood cancer worldwide, occurs at annual rates of between three
and four cases per 100 000 children under age 15 in most devel-
oped countries (Gurney, 1995; Parkin et al, 1998). Apart from
genetic disorders and ionizing radiation, there are no clear aetio-
logical risk factors for ALL (Ross et al, 1994; Pui, 1995; Greaves,
1997; Sandler and Ross, 1997). Investigations of more ubiquitous
exposures, including low frequency electromagnetic radiation,
have been inconsistent (Savitz et al, 1988; Feychting and Ahlbom,
1993; Linet et al, 1997). ALL is a heterogeneous disorder;
however, the majority of cases arise from cells which express
CD10 and CD19 cell-surface proteins consistent with B-lineage
differentiation (Pui et al, 1993; Kersey, 1997). This phenotype is
most common among children diagnosed with ALL between ages
2 and 5, corresponding to the observed age-specific incidence peak
(Gurney, 1995; Sandler and Ross, 1997). Greaves hypothesized
that the pathogenesis of ‘common’ B-lineage childhood ALL is a
two-step process (Greaves, 1988). In the first step, the develop-
mentally driven proliferation of B-precursor cells results in spon-
taneous mutation of a small population of cells. In the second
event, additional mutation or proliferation of the initially mutated
cells results from infectious exposures. In this model, delayed
exposure to common childhood infections leads to a leukaemic
outcome in a small number of children as a result of stimulation of
an expanded population of pre-leukaemic cells by virtue of later
infection. International and regional patterns of ALL incidence
demonstrating lower rates in developing countries support this
hypothesis (Greaves and Chan, 1986; Greaves, 1988, 1993).
In a large case–control study, the Children’s Cancer Group
(CCG) and the National Cancer Institute investigated patterns of
infection, surrogates of infection and risk of childhood ALL within
immunophenotypic subgroups. We hypothesized that children
with ALL would have had fewer childhood infections or have
been less likely to be in high-exposure environments (i.e. day care)
than controls.
METHODS
Case ascertainment
Cases of newly diagnosed ALL in children under 15 years of age
were ascertained from CCG member institutions throughout the
USA. To be eligible, cases had to be newly diagnosed with ALL
between 1 January 1989 and 15 June 1993, and the biological
mother had to be available for interview, speak English and have a
telephone in the household. Submission of a diagnostic bone
marrow specimen for immunophenotyping was required. A total
of 2081 eligible cases were identified during the study period and
a telephone interview completed for 1914 (92.1% of eligible
cases). The reasons for non-participation of 167 eligible cases are
shown in Table 1.
Control selection
Controls were randomly selected using a random digit-dialling
methodology previously described (Robison and Daigle, 1984)
and individually matched to cases on age (within 25% of age at
diagnosis of the case, with a maximum difference of ± 2 years),
race (white, black, or other, although this match was relaxed if a
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control was not obtainable for a given case) and telephone area
code and exchange. T-cell case–controls were also matched for
gender. A total of 2597 eligible controls were identified, of whom
1987 (76.5%) participated. One control was excluded because the
case was later found to be ineligible for the study. Reasons for
non-participation are shown in Table 1. Matched controls were not
found for 72 (3.6%) interviewed cases, resulting in 1842
case–control pairs (1704 sets of 1:1 match, 132 sets of 1:2 match
and 6 sets of 1:3 match).
Interview
The structured interview included questions about the subject’s
and mother’s health history, details of pregnancy and birth, child-
hood illnesses, illnesses of siblings and parental occupation. The
maternal interview included details of day care and pre-school
attendance (whether or not the index child ever attended day care
or pre-school, approximate dates of attendance, and average
number of hours per day). Day care or pre-school attendance in the
year prior to the ALL diagnosis (cases) or index date (controls)
was excluded to eliminate the possibility that symptoms of ALL
itself decreased attendance at day care or pre-school. There was
considerable overlap in day care and pre-school attendance times,
thus total time spent by a child in these activities were pooled for
analysis and is referred to as ‘day care’.
Mothers of cases and controls residing in a nine-state region of
the northeastern USA participated in an additional in-home inter-
view (Kleinerman et al, 1997; Hatch et al, 1998), which included
more detailed information on the childhood health history and
several common childhood illnesses.
Immunophenotype determinations
A standard panel of monoclonal antibodies was applied to all diag-
nostic bone marrow specimens to determine B- or T-lineage. A
subset of B-lineage leukaemias was further classified by the deter-
mination of cytoplasmic immunoglobulin. Cases were assigned to
one of the following mutually exclusive groups: T-cell ALL, early
pre-B ALL (B-lineage markers and cytoplasmic immunoglobulin
negative), pre-B ALL (B-lineage markers and cytoplasmic
immunoglobulin positive), B-lineage ALL – not otherwise speci-
fied (NOS) (B-lineage markers but cytoplasmic immunoglobulin
not performed), or unclassifiable. ‘Common’ childhood ALL was
defined as those cases determined to be of B-lineage expressing
both the CD10 and CD19 surface antigens, and diagnosed in
children aged 2–5 years.
Statistical analysis
Data were analysed for all types of ALL as a group and within
strata defined by age or immunophenotypic subtype. Conditional
logistic regression was used to calculate odds ratios (OR) and 95%
confidence intervals (CI) as an approximation of relative risk with
control for potential confounders. Tests for trend were performed
by treating levels of categorical data as continuous variables in the
logistic model. Analyses were adjusted for maternal education,
family income and race.
RESULTS
Study participants
The characteristics of 1842 cases and 1986 controls are shown in
Table 1. Cases were predominately male, white and between the
ages of 2 and 5 years. As compared to the cases, controls were
more often white, and were of higher socio-economic status as
evidenced by differences in income, and maternal and paternal
education (Table 1). Phenotypically, 9.9% of ALL cases were
T-lineage, 73.7% B-lineage, and no clear lineage could be
assigned in 16.4%. Among 1357 B-lineage cases, 633 (46.6%)
were designated ‘common’ childhood ALL.
Day care and pre-school (Table 2)
The likelihood of ever attending day care was similar among cases
and controls (OR 0.96; 95% CI 0.82–1.12). No inverse association
(protective effect) of day care attendance (vs no day care atten-
dance) was seen among children with ‘common’ ALL (OR 0.96,
Table 1 Characteristics of cases and controls
Cases Controls P-value
Maternal interview
Eligible 2081 2597
Completed interview 1914 (92.1%) 1987 (76.5%)
Matched set 1842 (88.6%) 1986 (76.5%)
Non-response 167 (7.9%) 610 (23.5%)
Physician refusal 41 (2.0%) –
Parental refusal 70 (3.4%) 457 (17.6%)
Lost to follow-up 18 (0.9%) 17 (0.7%)
Other 38 (1.8%) 136 (5.2%)
Gender – male 1018 (55.2%) 1076 (54.2%) 0.54
Age
<12 months 64 (3.5%) 81 (4.1%) 0.07
12–23 months 138 (7.5%) 189 (9.5%)
2–5 years 1020 (55.4%) 1038 (52.3%)
6–10 years 408 (22.2%) 466 (23.5%)
11–15 years 212 (11.5%) 212 (10.7%)
Race
White 1492 (81.0%) 1720 (86.6%) <0.01
Black 109 (5.9%) 94 (4.7%)
Hispanic 153 (8.3%) 121 (6.1%)
Other 88 (4.8%) 51 (2.6%)
Maternal education
= High school 797 (43.3%) 762 (38.4%) <0.01
Some post high school 592 (32.1%) 701 (35.3%)
College + 453 (24.6%) 523 (26.3%)
Paternal educationa
≤ High school 676 (41.8%) 638 (37.1%) <0.01
Some post high school 480 (29.7%) 510 (29.6%)
College + 462 (28.6%) 574 (33.4%)
Income
<10 000 217 (11.8%) 176 (8.9%) <0.01
10 000–19 999 390 (21.2%) 370 (18.6%)
20 000–29 999 433 (23.5%) 475 (23.9%)
30 000–39 999 334 (18.1%) 369 (18.6%)
40 000–49 999 204 (11.1%) 221 (11.1%)
50 000+ 250 (13.6%) 357 (18.0%)
Unknown 14 (0.8%) 18 (0.9%)
Immunophenotype
T-cell 183 (9.9%)
Early pre-B-cell 893 (48.5%)
Pre-B-cell 233 (12.6%)
B not specified 231 (12.5%)
Unknown 302 (16.4%)
aBased on 1618 cases and 1722 matched controls who responded to
paternal interview.236 JP Neglia et al
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95% CI 0.75–1.24). Detailed analysis by immunophenotypic cate-
gory revealed no additional associations with ORs of 1.00, 0.90,
0.86 and 0.75 for early pre-B ALL, pre-B ALL, B-cell NOS, and
T-cell ALL respectively (data not shown).
No significant associations were present for age at start of day
care or time in day care, defined as the total number of days that
the subject attended day care. Children with ‘common’ ALL were
as likely to have started day care before 6 months of age as
were controls. No effect was seen for starting day care later in
childhood.
Table 2 Day carea and risk of childhood ALL
‘Common’ ALL
Total ALL CD10+, CD19+, Age 2–5 All other ALL
Cases Controls Cases Controls Cases Controls
n = 1744 n = 1879 OR (95% CI) n = 633 n = 687 OR (95% CI)  n = 1111 n = 1192 OR (95% CI)
Any day care
No 914 949 1.00 413 429 1.00 501 520 1.00
Yes 830 930 0.96 (0.82–1.12) 220 258 0.96 (0.75–1.24) 610 672 0.95 (0.78–1.16)
Age at start of day care
No day care 914 949 1.00 413 429 1.00 501 520 1.00
≤ 6 months 165 201 0.91 (0.72–1.15) 67 78 1.02 (0.70–1.48) 98 123 0.85 (0.62–1.16)
7–12 months 66 76 0.99 (0.70–1.41) 27 28 1.23 (0.70–2.15) 39 48 0.90 (0.57–1.41)
13–24 months 114 113 1.06 (0.79–1.41) 41 49 0.88 (0.56–1.38) 73 64 1.18 (0.80–1.73)
> 24 months 185 540 0.94 (0.77–1.14) 85 103 0.84 (0.57–1.23) 400 437 0.96 (0.77–1.21)
Test for trend P = 0.712 P = 0.423 P = 0.995
Time in day care (days in
day care, regardless
how many hours/day)
No day care 914 949 1.00 413 429 1.00 501 520 1.00
<3 months 78 73 1.07 (0.77–1.50) 33 30 1.08 (0.64–1.83) 45 43 1.05 (0.67–1.62)
3–6 months 74 68 1.09 (0.76–1.55) 35 26 1.31 (0.75–2.30) 39 42 0.92 (0.58–1.48)
7–12 months 218 266 0.88 (0.71–1.10) 47 71 0.74 (0.48–1.12) 171 195 0.93 (0.72–1.22)
> 12 months 460 523 0.94 (0.78–1.13) 105 131 0.96 (0.70–1.32) 355 392 0.95 (0.75–1.20)
Test for trend P = 0.407 P = 0.560 P = 0.597
Day care before age 2
No 1399 1489 1.00 498 532 1.00 901 957 1.00
Yes 345 390 0.99 (0.84–1.17) 135 155 1.05 (0.80–1.37) 210 235 0.97 (0.78–1.20)
Time in day care
before age 2
No 1399 1489 1.00 498 532 1.00 901 957 1.00
< 3 months 63 54 1.23 (0.84–1.80) 22 16 1.43 (0.73–2.79) 41 38 1.12 (0.70–1.79)
3–6 months 51 40 1.30 (0.85–1.99) 25 11 2.33 (1.08–5.01) 26 29 0.96 (0.56–1.65)
7–12 months 71 95 0.87 (0.63–1.20) 25 51 0.61 (0.37–1.00) 46 44 1.17 (0.76–1.79)
> 12 months 160 201 0.91 (0.73–1.15) 63 77 1.09 (0.76–1.57) 97 124 0.83 (0.62–1.13)
Test for trend P = 0.461 P = 0.949 P = 0.458
aExcluding day care within 1 year before the diagnostic date (case) or reference date (control). Excluding subjects who were less than 1-year-old at diagnostic
date (case) or reference date (control). Odds ratios were derived from conditional logistic model adjusted for maternal race, education, and family income.
Table 3 Siblings and risk of childhood ALL
‘Common’ ALL
Total ALL CD10+, CD19+, Age 2–5 All other ALL
Cases Controls Cases Controls Cases Controls
n = 1744 n = 1879 OR (95% CI) n = 633 n = 687 OR (95% CI)  n = 1111 n = 1192 OR (95% CI)
Number of older siblings
None 730 813 1.00 258 287 1.00 472 526 1.00
1 634 659 1.08 (0.93–1.26) 236 234 1.11 (0.86–1.43) 398 425 1.06 (0.87–1.28)
³2 380 407 1.05 (0.88–1.26) 139 166 0.94 (0.70–1.26) 241 241 1.13 (0.90–1.41)
Test for trend P = 0.447 P = 0.842 P = 0.279
Interval to birth of next older sibling
No older sibling 730 813 1.00 258 287 1.00 472 526 1.00
≤5 years 855 911 1.05 (0.92–1.21) 314 333 1.03 (0.81–1.30) 541 578 1.03 (0.89–1.27)
> 5 years 159 155 1.18 (0.92–1.51) 61 67 1.08 (0.72–1.63) 98 88 1.23 (0.89–1.69)
Test for trend P = 0.200 P = 0.692 P = 0.219
Excluding subjects < 1 year old. Odds ratio were derived from conditional logistic model, adjusted for maternal race, education and family income.Infections, day care and childhood ALL 237
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Examination of day care within strata defined by age at
diagnosis of ALL revealed that among children under age 5, any
attendance at day care was associated with ALL risks similar to
those for children never attending day care (OR 0.90, 95% CI
0.75–1.09); risks were similarly close to unity among children
aged 6–10 years (OR –1.00, 95% CI 0.70–1.42), and for children
aged 11 and older (OR 1.20, 95% CI 0.78–1.87). Among these age
groups, no significant associations were seen between age at
starting day care or total number of day care visits and risk of
childhood ALL (data not shown). Similar results were obtained
when the analysis was restricted to day care attendance prior to
2 or 1 years of age.
Sibship characteristics (Table 3)
No differences between cases and controls were seen in the
number of older siblings. The time interval between the birth of
children with ALL and the birth of their next older sibling was
similar to that of their controls. No significant difference in sibship
size or interval were seen within B-lineage groups (data not
shown); however, children with T-lineage ALL were somewhat
more likely to have two or more older siblings than were their
controls (OR 1.88, 95% CI 1.05–3.36).
Health history, reported infections (Table 4)
Additional data on the occurrence of infections were available for
subjects participating in the in-home interview (see Methods). No
differences in reported lung infections or instances of gastro-
enteritis (vomiting and diarrhoea) were evident for the entire
group, among cases of ‘common’ ALL, or within B-lineage or
T-lineage ALL subsets (data not shown). Cases were no more
likely to have ever had pressure equalization (PE) tubes placed in
the ears (OR 0.97, 95% CI 0.69–1.37). Additionally, no significant
differences in ALL risk were found for age at, or occurrence of,
tonsillectomy, adenoidectomy, or appendectomy (data not shown).
The risk of ALL was reduced in those who experienced one or
more ear infections during the first year of life. Risk of ALL
decreased with increasing numbers of reported ear infections
during the first year of life with ORs of 0.86, 0.83, 0.71 and 0.69
for 1 episode, 2–4 episodes, 5+ episodes and continuous infections
respectively (trend P = 0.026). This significant inverse association
with ear infections in infancy was most evident in children with
‘common’ ALL (test of trend P = 0.016). Cases and controls were
equally as likely to report a history of varicella (OR 1.10, 95% CI
0.84–1.45) among all children with ALL and among ‘common’
ALL cases and controls (OR 0.96, 95% CI 0.56–1.51).
Infectous exposures in aggregate
An attempt was made to evaluate infectious exposure in aggregate
by the creation of a summary variable including day care data,
reported infections and sibship characteristics (Table 5, see foot-
note of the Table for grouping information). No clear trend was
evident when comparing the ‘intermediate’ or ‘most’ exposed
Table 4 Infection during infancy and risk of childhood ALL*
‘Common’ ALL
Total ALL CD10+, CD19+, Age 2–5 All other ALL
Cases Controls Cases Controls Cases Controls
n = 727 n = 637 OR (95% CI) n = 299 n = 270 OR (95% CI)  n = 428 n = 367 OR (95% CI)
Ear infection
None 386 302 1.00 150 111 1.00 236 191 1.00
Once 88 81 0.86 (0.61–1.22) 37 36 0.83 (0.49–1.40) 51 45 0.92 (0.58–1.45)
2–4 161 152 0.83 (0.63–1.09) 72 76 0.65 (0.43–1.00) 89 76 0.99 (0.69–1.43)
5 or more 75 83 0.71 (0.50–1.01) 36 40 0.64 (0.38–1.08) 39 43 0.75 (0.46–1.22)
Continuous 17 19 0.69 (0.35–1.37) 4 7 0.47 (0.13–1.67) 13 12 0.79 (0.35–1.79)
Test for trend P = 0.026 P = 0.016 P = 0.326
Lung infection
None 575 523 1.00 237 224 1.00 338 299 1.00
Once 80 58 1.32 (0.92–1.89) 33 25 1.32 (0.76–2.32) 47 33 1.33 (0.82–2.14)
2–4 56 36 1.48 (0.95–2.29) 24 14 1.79 (0.89–2.58) 32 22 1.28 (0.72–2.27)
5 or more 16 19 0.70 (0.35–1.40) 5 7 0.51 (0.15–1.74) 11 12 0.79 (0.34–1.86)
Test for trend P = 0.330 P = 0.403 P = 0.595
Vomiting or diarrhoea
None 545 192 1.00 222 213 1.00 323 279 1.00
Once 85 62 1.26 (0.89–1.80) 31 30 1.06 (0.62–1.84) 54 32 1.55 (0.96–2.49)
2 or more 97 83 1.07 (0.78–1.48) 46 27 1.57 (0.93–2.66) 51 56 0.78 (0.51–1.19)
Test for trend P = 0.428 P = 0.108 P = 0.622
Pressure equalization
(PE) tubes
No 649 565 1.00 269 241 1.00 380 324 1.00
Yes 77 71 0.97 (0.69–1.37) 30 29 0.94 (0.54–1.63) 47 42 0.96 (0.61–1.51)
Age at PE tubes
No 649 565 1.00 269 241 1.00 380 324 1.00
0–1 years 30 35 0.78 (0.47–1.30) 14 15 0.86 (0.40–1.85) 16 20 0.68 (0.34–1.34)
³2 years 47 35 1.18 (0.75–1.88) 16 14 1.01 (0.48–2.15) 31 21 1.28 (0.72–2.31)
aParticipants in the expanded in-person interview, excluding cases and controls under age of 18 months. Odds ratios derived from unconditional logistic model,
adjusted for maternal race, education, age and sex of index child and family income238 JP Neglia et al
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groups to the ‘least’ exposed group for all children with ALL or
the subset of children with ‘common’ ALL.
DISCUSSION
Three separate, but not exclusive, hypotheses of ALL pathogenesis
and infection deserve consideration. Citing the international varia-
tions in ALL rates, the development of the ALL ‘peak’ at different
times in different populations, and the higher rates of ‘common’
childhood ALL among more developed populations, Greaves
(1988) has suggested that delaying the occurrence of childhood
infections may, in some susceptible children, have an aetiological
role in the leukaemogenic process. Kinlen has suggested that
childhood ALL occurs as a rare response to a specific viral agent
or agents and that excesses of childhood leukaemia are promoted
by marked urban–rural population mixing, as a result of an
increased level of contacts between susceptible and infected indi-
viduals. Studies describing an increased occurrence of ALL in
British ‘New Towns’ and other areas of population mixing support
this theory (Kinlen, 1988, 1995; Kinlen et al, 1990; Alexander et
al, 1997). Smith (1997) has suggested an aetiological role for a
viral agent infecting a susceptible mother during pregnancy. JC
virus, a polyoma virus, has been proposed as a candidate virus, but
there are no data testing this hypothesis in childhood ALL. As part
of a large study of childhood ALL undertaken to evaluate risk
factors within biologically defined subgroups, we sought to test
the hypothesis that fewer infections during early childhood
increase the risk of ALL through the use of surrogate indicators of
infection including day care, sibship distribution and size, and
maternal reporting of her child’s illnesses.
Studies of children attending day care in the USA have shown a
higher frequency of upper respiratory infections, otitis media, and
gastroenteritis compared to children not attending day care
(Haskins and Kotch, 1986; Wald et al, 1991; Hansen, 1993;
Reeves et al, 1993). Therefore, we postulated that children with
ALL would attend day care less often and/or for shorter duration
than controls. Overall, and among children with ‘common’ ALL,
we found no protective effect. Moreover, examination of day care
‘exposure’ variables, including age at initiation of day care and
time in day care revealed no evidence for an association. No
‘threshold’ of day care exposure (time in day care) was present as
was reported for ‘creche’ attendance in Athens (Petridou et al,
1993).
In our study, mothers of children with ‘common’ ALL reported
fewer ear infections than control mothers. This association was
confined to the ‘common’ ALL group. We observed no differences
for reported episodes of colds, lung infections, or gastroenteritis
between the cases and controls. The reason for this apparent
discrepancy is unclear, although maternal recollection of ear infec-
tions may be more accurate than recall of the other infectious
diseases investigated, as the diagnosis of otitis media is virtually
always made by a physician and usually results in treatment with a
course of antibiotics. Infections less likely to result in a visit to the
physician or treatment with antibiotics may be less reliably
recalled. Nevertheless, it is noteworthy that no difference was
noted for the frequency of PE tubes (often placed for recurrent ear
infections) for the group overall or any of the leukaemia subsets.
The number of, and interval between, the birth of the index child
and older siblings were also investigated as a surrogate of expo-
sure to infection, based on the hypothesis that firstborn children or
those children whose siblings are much older are less likely to be
exposed to infection and thus at an increased risk of ALL (James,
1990). In contrast to our previous data showing an elevated risk of
ALL with longer birth intervals (> 5 years) (Kaye et al, 1991), no
evidence of an effect of birth order or interval was evident in this
investigation.
Given the breadth of interactions that determine any child’s
frequency or timing of infections, we attempted to create a
summary variable that would define the most and least infection
exposed groups. This variable, composed of day care attendance,
reported episodes of otitis media in infancy, sibship characteristics
and need for PE tubes did not support the hypothesis that the ‘most
exposed’ subset of children may be at decreased risk of ALL.
Analysis within the immunophenotypically defined ALL strata
and the ‘common’ ALL subset did not reveal any additional asso-
ciations.
Overall, the results of this analysis provide little support for a
relationship between early childhood infections and the risk of
childhood ALL. The data reported for ear infections in infancy
suggest a protective effect of early, repeated, non-specific
Table 5 Summarized infections exposure level and risk of childhood ALLa
‘Common’ ALL
Total ALL CD10+, CD19+, Age 2–5 All other ALL
Cases Controls Cases Controls Cases Controls
n = 727 n = 637 OR (95% CI) n = 299 n = 270 OR (95% CI)  n = 428 n = 367 OR (95% CI)
Least exposed 110 101 1.00 44 36 1.00 66 65 1.00
groupb
Intermediate exposed 519 450 1.06 (0.78–1.43) 207 193 0.87 (0.53–1.42) 312 257 1.21 (0.83–1.78)
groupb
Most exposed 98 86 1.13 (0.76–1.70) 48 41 1.07 (0.58–1.99) 50 45 1.16 (0.68–2.00)
groupb
Test for trend P = 0.541 P = 0.790 P = 0.511
aParticipants in the expanded in-person interview, excluding cases and controls under age of 18 months. bLeast exposed group: no day care prior to age of 2; no
older sibling; no ear infection, no lung infection during infancy, no history of PE tubes prior to age of 2. Most exposed group: had at least two of the following
conditions: had 7 or more months of day care before age of 2; had an older sibling within 5 years; had five or more ear infections or PE tubes prior to age of 2.
Intermediate exposed group: all children who did not fall into least or most exposed groups. Odds ratios were derived from unconditional logistic model,
adjusted for maternal race, education, the age and sex of index child and family incomeInfections, day care and childhood ALL 239
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infection, as most episodes of otitis are initiated by viral upper
respiratory infection. The specificity of this finding to the
‘common’ ALL subset provides additional support for this hypoth-
esis. In contrast, the results of the data reported on attendance at
day care and sibship characteristics do not.
It is possible that infections do impact on childhood ALL risk
and that the limitations of our study precluded ascertainment of
some of these relationships. Among worldwide populations there
may be significantly more heterogeneity of childhood infectious
exposures than within our study population. Thus, actual differ-
ences in occurrence and/or timing of infections may not have been
great enough within our population to identify small increases (or
decreases) in ALL risk. Another potential limitation is the absence
of data on the size of the day care facility the study children
attended. Thus, we were unable to stratify by day care size, which
may impact on the exposures a child has. Nevertheless, day care
visits, hours of attendance and age at first attendance of day care
provided little evidence of any effect, either among the group
overall or the ‘common’ ALL subset.
Similar investigations of childhood ALL aetiology currently are
underway in the UK and Canada. Results from these studies and
other hypothesis-directed investigations combining suspected
epidemiological and biological determinants for childhood ALL
should hopefully clarify any relationship between infection very
early in life and the subsequent risk of childhood ALL.
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